Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

News Conference News EuroPCR 2022

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

Yael L. Maxwell

May 17, 2022

News Daily News

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

Caitlin E. Cox

September 15, 2021

News Conference News

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

Shelley Wood

August 30, 2021

News Conference News ESC 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Shelley Wood

August 28, 2021

News Conference News AHA 2020

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Shelley Wood

November 15, 2020

News Conference News TCT 2020

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Shelley Wood

October 17, 2020

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Caitlin E. Cox

October 08, 2020

News Conference News EuroPCR 2018

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

Shelley Wood

May 24, 2018

Presentation JIM 2017

Ultimaster DES: Evidence for Every Clinical Scenario

Presenter: Marco Valgimigli

February 09, 2017

News Conference News TCT 2016

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

Shelley Wood

November 07, 2016

Presentation JIM 2016

DES safety and DAPT: The Ultimaster DES

Presenter: Corrado Tamburino

February 10, 2016

News Conference News TCT 2015

MASTER: Positive Results Seen for Bioresorbable-Polymer DES in STEMI

October 14, 2015

News Conference News TCT 2015

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

October 13, 2015

News Conference News EuroPCR 2015

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

Caitlin E. Cox

May 20, 2015

Presentation TCT 2014

Clinical Outcomes of Patients With High Risk Acute Coronary Syndrome Treated With a New Generation Drug-Eluting Stent, Ultimaster compared with Xience ? Results from CENTURY II___

Presenter: Kazushige Kadota

September 16, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms VI: Ultimaster

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Shigeru Saito

September 15, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

Presentation TCT 2013

Ultimaster: Sirolimus Elution from a Novel Bioabsorbable Polymer

Presenter: Shigeru Saito

October 27, 2013

Advertisement

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Shorter DAPT Sufficient Even in Complex HBR Patients: MASTER DAPT

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Latest Post-DES Drug Trial Tests Aspirin Monotherapy After 1 Month of DAPT

Stent Polymer Face-off Calls Bioresorbable Coatings Into Question

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Balking at Bulk: SORT-OUT VIII Hints at Clinical Edge for Thinner-Strut Stents

Ultimaster DES: Evidence for Every Clinical Scenario

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

DES safety and DAPT: The Ultimaster DES

MASTER: Positive Results Seen for Bioresorbable-Polymer DES in STEMI

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI

Clinical Outcomes of Patients With High Risk Acute Coronary Syndrome Treated With a New Generation Drug-Eluting Stent, Ultimaster compared with Xience ? Results from CENTURY II___

Cobalt-Chromium Sirolimus-Eluting Platforms VI: Ultimaster

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Ultimaster: Sirolimus Elution from a Novel Bioabsorbable Polymer

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content